Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

NCT01060202

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

NCT01402687

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

NCT00006013

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease

NCT00871702

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma

NCT01440556

Conditions: Allogeneic Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: A.O.U.San Giovanni Battista di Torino Torino, Italy

View Trial Details

Completed

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

NCT00021359

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hunterdon Regional Cancer Center Flemington, New Jersey, United States

Kimball Medical Center Lakewood, New Jersey, United States

South Jersey Regional Cancer Center Millville, New Jersey, United States

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States

View all 18 locations

View Trial Details

Completed

A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma

NCT01371227

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Nagoya, Japan

Okayama, Japan

View Trial Details

Completed

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

NCT00003341

Conditions: Anemia, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

View all 18 locations

View Trial Details

Completed

A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

NCT00807677

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

NCT00002502

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +69 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions